RECORDATORIO: Nuestro equipo de la línea de atención telefónica está trabajando a distancia y centrando su tiempo en ayudar a nuestros pacientes. Agradecemos a las farmacias, a los proveedores y a su personal que utilicen nuestros Portales de Farmacia y de Proveedores. Por favor, tenga en cuenta que si se pone en contacto con nosotros sobre un pago o una subvención, es más rápido enviarnos un correo electrónico a [email protected]. Le agradecemos su paciencia y esperamos seguir sirviéndole. Les deseamos a todos seguridad y buena salud durante estos momentos difíciles. El equipo de HealthWell
Tratamientos de la fibrosis quística
Status
ClosedThis fund is temporarily closed to new patients due to lack of sufficient funding. Please continue to visit our Disease Funds page often, as replenished funds reopen as quickly as possible. If you currently have a grant with HealthWell, your grant will remain active for the entire 12 month grant cycle or until you have exhausted your allocated grant amount, whichever comes first. You can continue to use your pharmacy card or submit requests for reimbursements during your designated grant cycle.
Assistance Type
Prescription Drug Copayor
Insurance premium (Medicare Part B only)
Maximum Award Level
Payment Type
Pharmacy CardMinimum Copay Reimbursement Amount
We encourage you to please use your HealthWell pharmacy card for any applicable charges as possible.
Minimum Premium Reimbursement Amount
Household Income Limit
500% of the Federal Poverty Level(adjusted for household size and high cost of living areas)
Treatments Covered
- Acetylcysteine
- Aerochamber Plus Flow-vu
- Albuterol Inhalation Sol
- Albuterol Sulfate
- Albuterol Sulfate Hfa
- Altera Nebulizer Handset (for Cayston)
- Alyftrek
- Amikacin
- Amikacin Liposome
- Amikacin Sulfate
- Arikayce
- Atrovent
- Atrovent Hfa
- Azactam
- Azithromycin
- Aztreonam
- Bactrim
- Bethkis
- Bevitrol
- Bronchitol
- Cayston
- Cefaclor
- Cefepime
- Ceftaroline Fosamil
- Ceftazidime
- Ceftazidime And Avibactam
- Chloramphenicol
- Chloramphenicol Sodium Succinate
- Cipro
- Ciprofloxacin
- Clarithromycin
- Clesrovimab-cfor
- Colistimethate
- Colistimethate; Colistimethate Sodium
- Colistin
- Coly-mycin M Parenteral
- Combivent Respimat
- Creon
- Cytotec
- Devilbiss Pediatric Aerosol Mask
- Dornase Alfa
- Durable Sidestream Handset
- Elexacaftor And Ivacaftor And Tezacaftor
- Elixophyllin
- Enflonsia Prefilled Syringe
- Firvanq
- Gentamicin Sulfate
- Handsets
- Hudson Rci Baby Disposable Mask
- Hudson Rci Micro Mist Handset
- Hudson T Up-draft Ii Handset
- Hypersal
- Hypertonic Saline Solution (3-7-10% Hts)
- Ibu
- Ibuprofen
- Imipenem And Cilastatin
- Ipratropium Bromide
- Ipratropium Bromide And Albuterol Sulfate
- Ipratropium Bromide Hfa
- Ivacaftor
- Kalydeco
- Kanamycin Sulfate
- Kitabis Pak
- Levalbuterol
- Levalbuterol Tartrate
- Levofloxacin
- Likmez
- Linezolid
- Lipase And Protease And Amylase
- Lumacaftor And Ivacaftor
- Mannitol
- Meropenem
- Metronidazole
- Misoprostol (oral)
- Mycobutin
- Nebusal
- Orkambi
- Pancreaze
- Panxyme Ph
- Pari Adult Aerosol Mask
- Pari Baby
- Pari Erapid Handset
- Pari Lc Plus Reusable Nebulizer Set
- Pari Lc Sidestream Handset
- Pari Lc Sprint Reusable Nebulizer Set
- Pari Lc Star Handset
- Pari Pep S (handset Only)
- Pari Smart Mask Kids
- Pari Trek S Combo Pack
- Pari Vios Handsets
- Pertzye
- Philips Innospire Go (mouthpiece Only)
- Piperacillin And Tazobactam
- Primaxin Iv
- Proair Respiclick
- Pulmosal (ph+)
- Pulmozyme
- Reltone
- Respirgard Ii Nebulizer Handset
- Respironics Side Stream Enhanced Neb Handset
- Rifabutin
- Rifampin
- Saline Solution
- Salmeterol Xinafoate
- Serevent Diskus
- Smz-tmp
- Sodium Chloride
- Streptomycin Sulfate
- Sulfamethoxazole And Trimethoprim
- Sulfatrim Pediatric
- Symdeko
- Tazicef
- Teflaro
- Tezacaftor And Ivacaftor
- Theo-24
- Theophylline
- Tigecycline
- Tobi
- Tobi Podhaler
- Tobramycin
- Tobramycin Inhalation Solution Pak
- Tobramycin Sulfate
- Trikafta
- Tygacil
- Tyzavan
- Urso Forte
- Ursodiol
- Vancocin
- Vancomycin Hcl
- Vanzacaftor And Tezacaftor And Deutivacaftor
- Ventolin Hfa
- Viokace
- Xopenex Hfa
- Zenpep
- Zithromax
- Zosyn
- Zyvox
Fund Definition
Assistance with the prescription drugs and biologics indicated for the treatment of cystic fibrosis.
Grant Utilization
HealthWell estimates that patients use an average of $2,700 during their 12-month grant period for this disease area.
About Our Cystic Fibrosis Treatments Fund
HealthWell’s Cystic Fibrosis Treatments Fund is designed to assist eligible people living with cystic fibrosis with cost-shares associated with CF-specific treatments. In addition, HealthWell is also able to consider assisting with the full cost of hypertonic saline solution, nebulizers paired with treatments, and certain handsets. We are committed to supporting the CF community and the established guidelines around our covered product list are meant to focus on the areas of greatest need for the majority of people living with CF. We understand there are additional areas to be addressed and, over time, it is our hope to be able to expand our coverage even further.
Please note that we are not able to assist with special requests outside of our covered product list at this time.
Do I Qualify?
HealthWell bases eligibility on an individual’s medical, financial and insurance situation. To qualify for HealthWell’s assistance, applicants must meet the following eligibility requirements:
-
Please make sure that HealthWell currently has a fund for your diagnosis/indication and that your medication is covered under that fund by visiting our Disease Funds listing. If we do not have a fund that currently covers your diagnosis, please check back as we frequently open and reopen programs as funding becomes available. The Foundation is able to help patients receiving treatment for indications for which we currently have an open fund. We can only assist with medications that have been prescribed to treat the disease/covered diagnosis. You will be asked to provide the Foundation with the patient’s diagnosis, which must be verified by a physician, nurse practitioner, or physician assistant’s signature. The patient must receive treatment in the United States.
-
To qualify for copayment assistance from HealthWell, you must have some form of health insurance (private insurance, Medicare, Medicaid, TriCare, etc.) that covers part of the cost of your treatment. Please note that in order to qualify for premium assistance through this fund, you must have Medicare Part B. The Foundation will refer patients without prescription insurance to other programs, such as manufacturer patient assistance programs.
-
-
If you are receiving treatment in the U.S. and have met the eligibility criteria as listed, you are ready to apply! Please note that you will be asked to provide a Social Security Number in order to create a grant. This information is gathered to eliminate duplicate applications and is kept secure and confidential.
About Cystic Fibrosis
Cystic fibrosis (CF) is a life-threatening, genetic disease that causes persistent lung infections and progressively limits the ability to breathe. In people with CF, a defective gene causes a thick, buildup of mucus in the lungs, pancreas and other organs. In the lungs, the mucus clogs the airways and traps bacteria leading to infections, extensive lung damage and eventually, respiratory failure. In the pancreas, the mucus prevents the release of digestive enzymes that allow the body to break down food and absorb vital nutrients. Source: Cystic Fibrosis Foundation
Additional Educational Resources
You may also visit our Resource List to view other copayment organizations that may provide assistance.